PRANTAL Drug Patent Profile
✉ Email this page to a colleague
When do Prantal patents expire, and what generic alternatives are available?
Prantal is a drug marketed by Schering and is included in one NDA.
The generic ingredient in PRANTAL is diphemanil methylsulfate. Additional details are available on the diphemanil methylsulfate profile page.
Summary for PRANTAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Patent Applications: | 224 |
DailyMed Link: | PRANTAL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PRANTAL
US Patents and Regulatory Information for PRANTAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | PRANTAL | diphemanil methylsulfate | TABLET;ORAL | 008114-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |